Our Research

At the Jacobs School, we advance research and discovery to improve health for all. Our multidisciplinary research advances basic and clinical science; we translate those discoveries into clinical care that improves health in our communities. With our eyes on the future, we are increasing the number of students and trainees who pursue careers in research, biomedical science and academic medicine.

Talal to Receive Award From Clinical Research Forum
2/24/25

The award recognizes UB work that leveraged facilitated telemedicine to cure hepatitis C in 90% of people with opioid use disorder.

previous next
Students Partake in Innovative Research on Dysautonomia
12/18/23

A number of medical students are gaining valuable clinical research experience studying autonomic disorders under the direction of Svetlana Blitshteyn, MD, a clinical associate professor of neurology at the Jacobs School of Medicine and Biomedical Sciences.

previous next
NEJM Study: For Chronic Subdural Hematomas, Blocking the Artery Supplying the Brain Covering Reduced Re-Operations Threefold
11/20/24

A dramatic reduction in repeat operations in patients surgically treated for chronic subdural hematoma was achieved when the artery supplying the brain covering was blocked, according to results published in the New England Journal of Medicine. 

previous next
UB-Founded Company Uses AI to Assist Surgeons Treating Brain Aneurysms in Real Time
12/18/23

QAS.AI awarded $1 million National Science Foundation grant for clinical evaluation in Buffalo and Florida.

previous next

Learn More About Our Research

Our Experts in the News

Recent Publications

See more

Recent Research Funding

  • A phase 3 double-blind study to evaluate the efficacy and safety of oral ozanimod compared to oral fingolimod in children and adolescents with relapsing-remitting multiple sclerosis. Michael Dwyer, III (Co-Investigator). Bristol Myers Squibb. $1,649,376. 6/1/2023-12/1/2032.
  • CTSA State University of New York at Buffalo. Zackary Falls (Contributor). National Center for Advancing Translational Sciences (NCATS). $29,204,726. 1/1/2025-12/1/2031.
  • Clinical and Translational Science Award. Core Operations Special Populations. Ralph Benedict (Co-Investigator). NIH. $29,204,726. 1/1/2025-12/1/2031.
  • Clinical and Translational Science Award. University at Buffalo Clinical and Translational Science Institute. Timothy Murphy (Principal Investigator). NIH. 1/1/2025-12/1/2031.
  • Molecular Physiology of NMDA Receptors. Gabriela Popescu (Principal Investigator). NINDS. $4,200,000. 5/1/2023-4/1/2031.
See more